BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 5,820.00
+20.00 (0.34%)
At close: Oct 2, 2025
BioNote Market Cap
BioNote has a market cap or net worth of 587.90 billion as of October 6, 2025. Its market cap has increased by 27.44% in one year.
Market Cap
587.90B
Enterprise Value
238.84B
Revenue
112.04B
Ranking
n/a
PE Ratio
4.91
Stock Price
5,820.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 587.90B, a decrease of -45.82%. That is a compound annual growth rate of -19.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 587.90B | 22.30% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1,084.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |